Treatment of primary acute genital herpes in guinea pigs by intraperitoneal administration of fluoropyrimidines.

AUTOR(ES)

Mayo, D R

RESUMO

FIAC [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine], FIAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil], and FMAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil] were evaluated for their efficacies in the treatment of genital infections with herpes simplex virus type 2 in guinea pigs. Intraperitoneal administration of these drugs in daily doses of 100 mg/kg of body weight initiated 24 h after virus inoculation and repeated 2 successive days thereafter inhibited development of genital lesions and reduced shedding of virus without evoking untoward reactions. In a comparative study with this 3-day dosage schedule, the efficacy of daily doses of 50 mg of FMAU per kg was greater than that of the same doses of FIAC and FIAU, in that order; all these were more effective than daily doses of 50, 100, or 200 mg of acyclovir or of 500 mg of phosphonoformic acid per kg. These differences in efficacy were enhanced when treatment was delayed for 2 to 3 days after inoculation.

Documentos Relacionados

• Acute conduction velocity changes in guinea-pigs after administration of diphenylhydantoin
• Lack of efficacy of AMP against recrudescent genital herpes infections in guinea pigs.
• Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigs.
• Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.
• Primary acute histoplasmosis in guinea pigs exposed to aerosolized Histoplasma capsulatum.